Ignite Creation Date:
2025-12-26 @ 11:47 AM
Ignite Modification Date:
2026-02-28 @ 6:47 PM
Study NCT ID:
NCT03709316
Status:
UNKNOWN
Last Update Posted:
2021-06-02
First Post:
2018-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Sponsor:
Zai Lab (Shanghai) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-09-19
First Submit QC Date:
None
Study First Post Date:
2018-10-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-31
Last Update Post Date:
2021-06-02
Last Update Post Date Type:
ACTUAL